Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP511305.RAEa1QL3IVKaF9KJFkXfgfqJmf6YbvIln0H32t5Kui3GU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP511305.RAEa1QL3IVKaF9KJFkXfgfqJmf6YbvIln0H32t5Kui3GU130_assertion type Assertion NP511305.RAEa1QL3IVKaF9KJFkXfgfqJmf6YbvIln0H32t5Kui3GU130_head.
- NP511305.RAEa1QL3IVKaF9KJFkXfgfqJmf6YbvIln0H32t5Kui3GU130_assertion description "[Analysis of RaLP in melanoma signal transduction pathways revealed that (a) when ectopically expressed in RaLP-negative melanocytes and nonmetastatic melanoma cells, it functions as a substrate of activated insulin-like growth factor-1 and epidermal growth factor receptors and increases Ras/mitogen-activated protein kinase (MAPK) signaling and cell migration, whereas (b) its silencing in RaLP-positive melanoma cells abrogates cell migration in vitro, without affecting MAPK signaling, suggesting that RaLP activates both Ras-dependent and Ras-independent migratory pathways in melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP511305.RAEa1QL3IVKaF9KJFkXfgfqJmf6YbvIln0H32t5Kui3GU130_provenance.
- NP511305.RAEa1QL3IVKaF9KJFkXfgfqJmf6YbvIln0H32t5Kui3GU130_assertion evidence source_evidence_literature NP511305.RAEa1QL3IVKaF9KJFkXfgfqJmf6YbvIln0H32t5Kui3GU130_provenance.
- NP511305.RAEa1QL3IVKaF9KJFkXfgfqJmf6YbvIln0H32t5Kui3GU130_assertion SIO_000772 17409413 NP511305.RAEa1QL3IVKaF9KJFkXfgfqJmf6YbvIln0H32t5Kui3GU130_provenance.
- NP511305.RAEa1QL3IVKaF9KJFkXfgfqJmf6YbvIln0H32t5Kui3GU130_assertion wasDerivedFrom befree-20150227 NP511305.RAEa1QL3IVKaF9KJFkXfgfqJmf6YbvIln0H32t5Kui3GU130_provenance.
- NP511305.RAEa1QL3IVKaF9KJFkXfgfqJmf6YbvIln0H32t5Kui3GU130_assertion wasGeneratedBy ECO_0000203 NP511305.RAEa1QL3IVKaF9KJFkXfgfqJmf6YbvIln0H32t5Kui3GU130_provenance.